Risk Associated With Surgery Within 12 Months After Coronary Drug-Eluting Stent Implantation

Journal of the American College of Cardiology

Volumn 68, Issue 24, 2016, Pages 2622-2632

  Egholm, Gro ^a   Kristensen, Steen Dalby ^a   Thim, Troels ^a   Olesen, Kevin K W ^a   Madsen, Morten ^a   Jensen, Svend E ^b   Jensen, Lisette O ^c   Sørensen, Henrik T ^a   Bøtker, Hans E ^a   Maeng, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

coronary artery disease; epidemiology; interventional cardiology; noncardiac surgery

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CYCLOOXYGENASE 2 INHIBITOR; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; PURINERGIC RECEPTOR BLOCKING AGENT;

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY STENTING; DENMARK; DISEASE REGISTRY; DRUG ELUTING CORONARY STENT; EVEROLIMUS ELUTING CORONARY STENT; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACLITAXEL ELUTING CORONARY STENT; PERCUTANEOUS CORONARY INTERVENTION; POPULATION RESEARCH; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; SIROLIMUS ELUTING CORONARY STENT; SURGICAL RISK; SURVIVAL TIME; ZOTAROLIMUS ELUTING CORONARY STENT; ADVERSE EFFECTS; CLINICAL TRIAL; DRUG ELUTING STENT; FOLLOW UP; INCIDENCE; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL ISCHEMIA; ODDS RATIO; POSTOPERATIVE COMPLICATIONS; PROCEDURES; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TIME FACTOR; TRENDS;

AGED; DENMARK; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ODDS RATIO; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 85004043417     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.09.967     Document Type: Article

References (24)

1. 1 Urban, P., Meredith, I.T., Abizaid, A., et al. Polymer-free drug-coated coronary stents in patients at high bleeding risk. N Engl J Med 373 (2015), 2038–2047.
2. 2 Finn, A.V., Nakazawa, G., Joner, M., et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 27 (2007), 1500–1510.
3. 3 Joner, M., Finn, A.V., Farb, A., et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 48 (2006), 193–202.
4. 4 Kristensen, S.D., Knuuti, J., Saraste, A., et al. 2014 ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35 (2014), 2383–2431.
5. 5 Levine, G.N., Bates, E.R., Bittl, J.A., et al. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68 (2016), 1082–1115.
6. 6 Hollis, R.H., Graham, L.A., Richman, J.S., et al. Adverse cardiac events in patients with coronary stents undergoing noncardiac surgery: a systematic review. Am J Surg 204 (2012), 494–501.
7. 7 Alshawabkeh, L.I., Banerjee, S., Brilakis, E.S., Systematic review of the frequency and outcomes of non-cardiac surgery after drug-eluting stent implantation. Hellenic J Cardiol 52 (2011), 141–148.
8. 8 Hawn, M.T., Graham, L.A., Richman, J.S., et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310 (2013), 1462–1472.
9. 9 Hawn, M.T., Graham, L.A., Richman, J.R., et al. The incidence and timing of noncardiac surgery after cardiac stent implantation. J Am Coll Surg 214 (2012), 658–666.
10. 10 Cruden, N.L., Harding, S.A., Flapan, A.D., et al. Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery. Circ Cardiovasc Interv 3 (2010), 236–242.
11. 11 Tokushige, A., Shiomi, H., Morimoto, T., et al. Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI/CABG Registry Cohort-2. Circ Cardiovasc Interv 5 (2012), 237–246.
12. 12 Schmidt, M., Maeng, M., Jakobsen, C.J., et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol 2 (2010), 137–144.
13. 13 Schmidt, M., Pedersen, L., Sorensen, H.T., The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol 29 (2014), 541–549.
14. 14 Sorensen, H.T., Sabroe, S., Olsen, J., A framework for evaluation of secondary data sources for epidemiological research. Int J Epidemiol 25 (1996), 435–442.
15. 15 Thygesen, S.K., Christiansen, C.F., Christensen, S., et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol, 11, 2011, 83.
16. 16 Egholm, G., Madsen, M., Thim, T., et al. Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention. Clin Epidemiol 8 (2016), 415–423.
17. 17 Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. Eur Heart J 33 (2012), 2551–2567.
18. 18 Helweg-Larsen, K., The Danish Register of Causes of Death. Scand J Public Health 39:Suppl 7 (2011), 26–29.
19. 19 Pedersen, C.B., The Danish Civil Registration System. Scand J Public Health 39:Suppl 7 (2011), 22–25.
20. 20 Saia, F., Belotti, L.M., Guastaroba, P., et al. Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery?. Circ Cardiovasc Qual Outcomes 9 (2016), 39–47.
21. 21 Holcomb, C.N., Graham, L.A., Richman, J.S., et al. The incremental risk of coronary stents on postoperative adverse events: a matched cohort study. Ann Surg 263 (2016), 924–930.
22. 22 Holcomb, C.N., Graham, L.A., Richman, J.S., et al. The incremental risk of noncardiac surgery on adverse cardiac events following coronary stenting. J Am Coll Cardiol 64 (2014), 2730–2739.
23. 23 Graham, L.A., Hollis, R.H., Richman, J.S., Hawn, M.T., Frequency of surgery cancellations associated with myocardial infarction or death 6 months after coronary stent placement. JAMA Surg 150 (2015), 1199–1201.
24. 24 Egholm, G., Thim, T., Olesen, K.K., et al. Dual anti-platelet therapy after coronary drug-eluting stent implantation and surgery-associated major adverse events. Thromb Haemost 116 (2016), 172–180.